Overview
A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis
Status:
Completed
Completed
Trial end date:
2016-09-01
2016-09-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
This study is a prospective randomized controlled study of EVONAIL® solution for prevention or treatment of onycholysis in patients with breast cancer receiving docetaxel chemotherapy.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Samsung Medical CenterTreatments:
Pharmaceutical Solutions
Criteria
Inclusion Criteria:- Patients with breast cancer receiving adjuvant/neoadjuvant docetaxel chemotherapy
Exclusion Criteria:
- Patients with breast cancer receiving palliative docetaxel chemotherapy
- Patients having onycholysis before docetaxel treatment